For IPO Boutique's "scale of 1 to 5" BUY rating on Prothena Corporation plc, and our comprehensive analysis, click "Buy Market Research".
Prothena Corporation plc Quote & Chart - Click for current quote - PRTA
About Prothena Corporation plc (adapted from Prothena Corporation plc prospectus): Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a pipeline of novel investigational therapeutics with the potential to change the course of devastating rare peripheral amyloid and neurodegenerative diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PRTA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
